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Abstract: AIMS OF THE STUDY Based on an incidental observation made in the context of the Swiss
National Science Foundation (SNSF) Project 67 ldquo;End-of-life decision-making in extremely low birth
weight infants in Switzerlandrdquo;, this retrospective multicentre observational study aimed to analyse
circumstances of delivery room deaths after late termination of pregnancy (LTOP) in Switzerland over a
3-year period. METHODS All delivery room deaths (including live and stillbirths) following LTOP among
infants with a gestational age between 22 0/7 and 27 6/7 weeks at the nine Swiss level III perinatal centres
between 1 July 2012 and 30 June 2015 were analysed. Indications for LTOP were classified as either (a)
maternal emergencies or (b) fetal anomalies severe enough to cause significant maternal psychological
distress. Whenever possible, specific diagnoses were recorded. Spontaneous intrapartum death and fetal
death caused by injection of a cardioplegic drug were distinguished for stillborn infants. RESULTS A total
of 465 delivery room deaths among extremely low gestational age newborns (ELGANs) were identified
over the 3-year study period of the SNSF project. Of these, 195 (42%) occurred in the context of LTOP.
Central nervous system malformations, chromosomal anomalies, severe congenital heart disease, multiple
malformations and maternal emergencies accounted for 70% of all LTOPs. LTOPs resulted in live births
in 76 (39%) cases. No correlation between gestational age and rate of live births was observed. Fetal
death caused by injection of a cardioplegic drug was documented in only three cases. All infants born
alive after LTOP died in the delivery room without resuscitation attempts. The use of drugs for palliative
care in these patients was either rare or, alternatively, incompletely documented. CONCLUSION LTOPs
contribute significantly to mortality rates among ELGANs and should therefore be included in perinatal
registries. Uniform reporting of LTOPs should be established. Infants born alive after LTOP are entitled
to comprehensive palliative care like any other infant born under different circumstances. Development
of national guidelines for LTOPs (including the role of fetal death caused by injection of a cardioplegic
drug and palliative birth as an alternative to induced abortion) would be highly desirable to guarantee
acceptable standards of care.
DOI: https://doi.org/10.4414/smw.2020.20186






The following work is licensed under a Creative Commons: Attribution-NonCommercial-NoDerivatives
4.0 International (CC BY-NC-ND 4.0) License.
Originally published at:
Berger, Fabienne; Bucher, Hans Ulrich; Fauchère, Jean-Claude; Schulzke, Sven; Berger, Thomas Michael
(2020). Overlapping borders: limit of viability and late terminations of pregnancy - a retrospective
multicentre observational study. Swiss Medical Weekly, 150:w20186.
DOI: https://doi.org/10.4414/smw.2020.20186
2
Original article | Published 07 February 2020 | doi:10.4414/smw.2020.20186
Cite this as: Swiss Med Wkly. 2020;150:w20186
Overlapping borders: limit of viability and late
terminations of pregnancy – a retrospective
multicentre observational study
Berger Fabiennea, Bucher Hans U.b, Fauchère Jean-Claudeb, Schulzke Sven M.ac, Berger Thomas M.d, for the Swiss
End-of-Life Study Group*
a University of Basel Medical School, Basel, Switzerland
b Department of Neonatology, University Hospital Zurich and University of Zurich, Switzerland
c University Children’s Hospital Basel UKBB, Basel, Switzerland
d NEO FOR NAMIBIA, Lucerne, Switzerland
* The Swiss Neonatal End-of-Life Study Group includes the following local coordinators (listed in alphabetical order of study site): Aarau: Kantonsspital Aarau,
Kinderklinik (P Meyer, C Anderegg); Basel: Universitäts-Kinderspital beider Basel, Abteilung für Neonatologie (S Schulzke); Bern: Frauenklinik und Medizinis-
che Kinderklinik, Abteilung für Neonatologie (O Ahrens, M Nelle, D Grütter), Inselspital, Abteilung für Intensivpflege, Universitätskinderklinik (B Wagner); Chur:
Kantonsspital Graubünden, Kinderklinik (W Bär, Y Cajochen); Genève: HUG, Clinique de Pédiatrie, Département de Pédiatrie / Hôpital des Enfants (RE Pfis-
ter); Lausanne: CHUV, Département de Pédiatrie (M Roth-Kleiner, JF Tolsa), CHUV, SI Pédiatriques, Médico-Chirurgicaux (J Cotting); Luzern: Kantonsspital
Luzern, Kinderspital Pädiatrie (TM Berger); St. Gallen: Kantonsspital St. Gallen, Klinik für Geburtshilfe und Gynäkologie (A Malzacher), Ostschweizer Kinder-
spital, Intensivpflege- und Frühgeburtenstation (G Jäger); Zürich: USZ, Klinik für Neonatologie, Universitätsspital Zürich (D Bassler, JC Fauchère), Abteilung
für Intensivmedizin und Neonatologie, Universitätskinderklinik Zürich (B Frey).
Summary
AIMS OF THE STUDY: Based on an incidental observa-
tion made in the context of the Swiss National Science
Foundation (SNSF) Project 67 “End-of-life decision-mak-
ing in extremely low birth weight infants in Switzerland”,
this retrospective multicentre observational study aimed to
analyse circumstances of delivery room deaths after late
termination of pregnancy (LTOP) in Switzerland over a
3-year period.
METHODS: All delivery room deaths (including live and
stillbirths) following LTOP among infants with a gestational
age between 22 0/7 and 27 6/7 weeks at the nine Swiss
level III perinatal centres between 1 July 2012 and 30
June 2015 were analysed. Indications for LTOP were clas-
sified as either (a) maternal emergencies or (b) fetal
anomalies severe enough to cause significant maternal
psychological distress. Whenever possible, specific diag-
noses were recorded. Spontaneous intrapartum death and
fetal death caused by injection of a cardioplegic drug were
distinguished for stillborn infants.
RESULTS: A total of 465 delivery room deaths among
extremely low gestational age newborns (ELGANs) were
identified over the 3-year study period of the SNSF project.
Of these, 195 (42%) occurred in the context of LTOP. Cen-
tral nervous system malformations, chromosomal anom-
alies, severe congenital heart disease, multiple malforma-
tions and maternal emergencies accounted for 70% of all
LTOPs. LTOPs resulted in live births in 76 (39%) cases.
No correlation between gestational age and rate of live
births was observed. Fetal death caused by injection of
a cardioplegic drug was documented in only three cases.
All infants born alive after LTOP died in the delivery room
without resuscitation attempts. The use of drugs for pallia-
tive care in these patients was either rare or, alternatively,
incompletely documented.
CONCLUSION: LTOPs contribute significantly to mortality
rates among ELGANs and should therefore be included
in perinatal registries. Uniform reporting of LTOPs should
be established. Infants born alive after LTOP are entitled
to comprehensive palliative care like any other infant born
under different circumstances. Development of national
guidelines for LTOPs (including the role of fetal death
caused by injection of a cardioplegic drug and palliative
birth as an alternative to induced abortion) would be highly
desirable to guarantee acceptable standards of care.
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Introduction
Swiss law on induced abortion and induced abortion
rates
In Switzerland, induced abortion is legal up to the 12th
week of pregnancy at the written request of a pregnant
woman who claims that she is in a state of distress (so-
called “Fristenregelung” or “régime du délai”). Beyond the
first trimester, termination of a pregnancy is exempt from
penalty if it is deemed necessary by a physician to prevent
the pregnant woman from sustaining serious physical in-
jury or serious psychological distress (so-called “Indika-
tionsregelung” or “régime des indications”). The Swiss
Criminal Code stipulates that the risk to the mother must
be greater the more advanced the pregnancy is [1], imply-
ing that the value of a fetus increases with advancing ges-
tational age.
Worldwide, annual induced abortion rates have decreased
from 40 induced abortions per 1000 women aged 15–44
years in 1990–1994 to 35 in 2010–2014 [2]. According to
the most recent “Abortion Worldwide 2017” report from
the Guttmacher Institute [3], Switzerland has one of the
lowest induced abortion rates worldwide (5 induced abor-
tions per 1000 women aged 15–49 years in 2014). The
Swiss Federal Statistical Office estimates that approxi-
mately 95% of these induced abortions occur prior to the
12th week of pregnancy and only 5% at a later stage [4].
Late termination of pregnancy
There is no generally accepted definition of what consti-
tutes late termination of pregnancy (LTOP), except that it
describes the termination of an advanced pregnancy – the
threshold ranging from 12 to 20 or even >24 weeks of ges-
tation [5, 6].
In a retrospective cohort study of all deaths among ex-
tremely low gestational age newborns (ELGANs) born be-
tween 22 and 27 completed weeks of gestation in Switzer-
land over a 3-year period [7], researchers unexpectedly
found that 42% of all delivery room deaths in this popu-
lation followed induction of labour for LTOP. Subsequent-
ly, the Swiss National Ethics Committee explored legal,
medical and ethical aspects of LTOP. The Committee sum-
marised its findings in a recently published position state-
ment [8]. Presumably, the vast majority of LTOPs in our
cohort were performed by early labour induction. Surgical
terminations are only rarely performed at this stage of
pregnancy in Switzerland [9]. Details of the methods used
for LTOP were not collected.
The aim of the present study was to analyse in depth indi-
cations for LTOP, rates of live and stillbirths after LTOP, as
well as circumstances of delivery room deaths of live born
infants after LTOP in Switzerland over a 3-year period.
Methods
This retrospective multicentre observational study was un-
dertaken at nine Swiss Level III perinatal centres. From
data of the Swiss National Science Foundation (SNSF)
Project 67 “End-of-life decision-making in extremely low
birth weight infants in Switzerland”, all delivery room
deaths following induction of labour for LTOP among EL-
GANs (gestational age between 22 0/7 and 27 6/7 weeks)
over a 3-year period (1 July 2012 to 30 June 2015) were
analysed. Both live and stillborn infants were included. Be-
cause of the initial study design, LTOPs at higher gesta-
tional ages were not recorded.
Gestational age was defined as the postmenstrual age in
weeks and days, and was the best obstetric estimate based
on ultrasound and/or date of the beginning of the last men-
strual period. The period between 24 0/7 weeks and 24 6/7
weeks, for example, is termed 24 completed weeks of ges-
tation: the fetus has completed 24 weeks and is in the 25th
week of gestation.
Patients were identified using clinical records, electronic
databases and birth log books. De-identified data were en-
tered into REDCap (Research Electronic Data Capture), a
secure online database, by trained research assistants on-
site. The system featured easy-to-use online screen forms
and electronic data validation checks to minimise data en-
tering errors. Confidentiality was assured by password pro-
tection.
The indications for LTOP were classified as (a) maternal
emergencies, such as haemorrhage, sepsis secondary to
chorioamnionitis, preeclampsia or HELLP syndrome (hy-
pertension, elevated liver enzymes, low platelets) or acute
psychiatric disorders; and (b) fetal anomalies severe
enough to cause significant maternal psychological dis-
tress. The latter were further subdivided into the following
categories according to the organ system mostly affected
by the malformation: central nervous system (CNS) mal-
formations, congenital heart diseases (CHD), pulmonary
malformations (including pleural effusions), renal malfor-
mations, and skeletal disorders. The term multiple malfor-
mations was used when multiple organ systems were in-
volved. The term chromosomal anomalies was used when
known genetic disorders were diagnosed regardless of the
organ systems affected. Disorders that could not be classi-
fied into one of the above categories were listed individu-
ally.
For each patient, date and time of birth, as well as the peri-
natal centre where the infant was born, were registered.
Additional demographic data included gestational age,
birth weight, sex and whether the infant was a singleton
or child from a multiple birth. For stillborn infants, we at-
tempted to determine whether fetal death occurred spon-
taneously or resulted from cardiac injection of digoxin or
potassium chloride to stop the fetal heart. For live born in-
fants, the type of delivery, any postnatal interventions (e.g.,
the administration of sedatives and/or analgesics) and time
until death were recorded.
Data collection was limited to the level III perinatal centres
at the University Hospitals of Basel, Bern, Geneva, Lau-
sanne and Zurich, and the level III perinatal centres at the
Cantonal Hospitals of Aarau, Chur, Lucerne and St Gallen.
Statistical analysis
Continuous variables are presented as median and range,
dichotomous variables are presented as absolute numbers
and percentages.
Ethics approval
Data collection and evaluation for this study were ap-
proved by the Swiss Federal Commission for Privacy Pro-
tection in medical research and the Swiss ethical review
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boards (KEK-ZH-Nr2014-0551 and KEK-ZH-
Nr2014-0552).
Results
Delivery room deaths and LTOPs among ELGANs
Over the 3-year study period, a total of 465 delivery room
deaths among ELGANs (22–27 completed weeks of gesta-
tion) were identified. Of these, 195 (42%) occurred in the
context of LTOP, and resulted in live births in 76 (39%)
and stillbirths in 119 (61%) of cases (fig. 1).
Demographics of delivery room deaths after LTOP
A total of 126 (65%) LTOPs occurred at 22–23 weeks of
gestation, 36 (18%) at 24 weeks of gestation, and 33 (17%)
at 25–27 weeks of gestation. The rate of live births did not
correlate with gestational age and varied between 11% and
50% (fig. 2).
Demographic data were comparable between live and still-
born infants with a median gestational age and birthweight
of 23 3/7 weeks and 550 g versus 24 0/7 weeks and 530 g,
respectively (table 1). Fetal death caused by injection of a
cardioplegic drug was documented in three cases (for de-
tails see table S1 in appendix 1).
Indications for LTOP
Overall, CNS malformations, including myelomeningoce-
les (n = 46), chromosomal anomalies (n = 29), severe CHD
(n = 22), multiple malformations (n = 18) and maternal
emergencies (n = 22), accounted for 70% of all LTOPs
Figure 1: Overview of all delivery room (DR) deaths recorded by the SNSF project 67 over a 3-year period from 1 July 2012 to 30 June 2015;
in 195 cases labour was induced for late termination of pregnancy (LTOP).
Figure 2: Numbers of later-terminations of pregnancy by gestational age, with rates of live and still births (n and %).
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(table 2). The most frequent diagnoses for each of the
above categories are listed in table 3.
When data were analysed separately for LTOPs below the
current limit of viability in Switzerland (22 0/7 to 23 6/7),
at the grey zone of the current limit of viability in Switzer-
land (24 0/7 to 24 6/7) and above the current limit of vi-
ability in Switzerland (25 0/7 to 27 6/7), some variations
between the five most common indications were noted. At
less than 24 completed weeks of gestation, CNS malforma-
tions were the leading cause for LTOP (accounting for 29%
in this age group), whereas at the grey zone of the limit
of viability, CNS malformations, chromosomal anomalies,
and CHD were listed with similar frequencies (account-
ing for 8%, 11% and 14% in this age group, respective-
ly). Above the limit of viability, CNS malformations and
chromosomal anomalies were predominant (accounting for
18% and 21%, respectively) (fig. 3).
Most of the LTOPs for maternal emergencies occurred at
less than 24 completed weeks of gestation (82%) and re-
sulted in 11 live births and 7 stillbirths. Only four patients
were delivered with a gestational age ≥24 0/7 weeks (i.e.,
beyond the limit of viability suggested in the current Swiss
guidelines [10]), three of whom were born alive. Of these,
two infants weighed less than 500 g and one infant was de-
livered owing to chorioamnionitis; none of them received
any life-sustaining therapies (fig. 4).







Gestational age in weeks, median
(range)
23 3/7
(22 0/7 to 27 6/7)
23 3/7
(22 1/7 to 27 6/7)
24 0/7
(22 0/7 to 27 6/7)
Birthweight in g,
median (range)
540 (110–1300) 550 (200–1300) 530 (110–1250)
Male gender, n (%) 104 (53%) 42 (55%) 62 (52%)
Multiples, n (%) 16 (8%) 8 (11%) 8 (7%)
Table 2: Indications for late termination of pregnancy with gestational age, birthweight and rate of live births.
Indication for LTOP n % of all LTOP Median gestational age in
weeks
(range)




CNS malformations 46 23.6 23 3/7





Chromosomal anomalies 28 14.3 23 2/7





CHD 23 11.8 23 4/7





Multiple malformations 17 8.7 23 3/7





Miscellaneous 60 30.8 23 6/7





Maternal emergencies 21 10.8 23 0/7





Total 195 100 23 3/7





CNS = central nervous system; CHD = congenital heart disease; LTOP = late termination of pregnancy. An expanded version of this table is available in table S2, appendix 1.
Table 3: Most frequent diagnoses listed for organ system categories and maternal emergencies.
Indication for LTOP Most frequent specific diagnoses
CNS malformations (n = 46) Myelomeningocele (n = 11)
Massive hydrocephalus (n = 10)
Agenesis of corpus callosum (n = 5)
Chromosomal anomalies (n = 28) Trisomy 21 (n = 10)
Trisomy 18 (n = 5)
Triploidy (n = 4)
CHD (n = 23) Hypoplastic left heart syndrome (n = 7)
Unspecified complex CHD (n = 6)
Pulmonary malformations (n = 5) Congenital diaphragmatic hernia (n = 2)
Renal malformations (n = 8) Bilateral renal agenesis (n = 3)
Bilateral multicystic dysplastic kidneys (n = 2)
Skeletal disorders (n = 11) (Suspected) Osteogenesis imperfecta (n = 5)
Thanatophoric dysplasia type 1 (n = 2)
Multiple malformations (n = 17) Unspecified multiple malformations (n = 5)
Fetal akinesia syndrome (n = 3)
Maternal emergencies (n = 21) Chorioamnionitis (n = 8)
(Pre)eclampsia, HELLP syndrome (n = 8)
Psychiatric disorder (n = 3)
CNS = central nervous system; CHD = congenital heart disease; HELLP = hypertension, elevated liver enzymes, low platelets; LTOP = late termination of pregnancy
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Live births after LTOP
Live births occurred frequently after LTOP, and were ob-
served both after Caesarean section (n = 16, 21%) and
vaginal delivery (n = 60, 79%). For the most common indi-
cations, live births were observed in 64% (maternal emer-
gencies), 48% (CNS malformations), 41% (CHD), 33%
(multiple malformations) and 21% (chromosomal anom-
alies) of cases (table 2 and table S2 in appendix 1).
All infants born alive after LTOP (n = 76) died in the
delivery room without resuscitation attempts. Time until
death among live born infants was documented for only
10 (13%) patients and ranged from 2 minutes to 4 hours.
The use of analgo-sedative drugs for palliative care of the
neonate was reported for only one patient; it was therefore
either extremely rare or, alternatively, incompletely docu-
mented.
Discussion
Delivery room deaths and LTOPs among ELGANs
A large proportion (42%) of delivery room deaths among
ELGANs in Swiss Level III perinatal centres occur after
LTOP (fig. 1). This unexpected finding can in part be ex-
plained by the fact that life-sustaining therapies are never
Figure 3: Comparison of the indications for LTOP at <24 completed weeks (below current limit of viability in Switzerland), 24 weeks (grey zone
of current limit of viability in Switzerland) and ≥24 completed weeks (above current limit of viability in Switzerland) (CNS = central nervous sys-
tem; CHD = congenital heart disease; LTOP = late termination of pregnancy; GA = gestational age).
Figure 4: Demographics and gestational age categories (22 0/7 to 23 6/7: below current limit of viability in Switzerland, 24 0/7 to 24 6/7: grey
zone of current limit of viability in Switzerland; 25 0/7 to 27 6/7: above current limit of viability in Switzerland) of late terminations of pregnancy
for maternal emergencies and fetal anomalies (GA = gestational age; BW = birth weight).
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initiated after LTOP. The infant’s death is the anticipated
outcome. In contrast, in infants born at or beyond the
limit of viability (defined as ≥24 0/7 weeks of gestation
in Switzerland) after spontaneous labour or induction of
labour for reasons other than LTOP, resuscitation is usually
attempted and rarely fails (in less than 10% of cases) [7].
Such infants are then admitted to a neonatal intensive care
unit (NICU) for provisional intensive care, where the clin-
ical evolution will help to clarify whether life-sustaining
therapies should be continued or withdrawn. The Swiss
Recommendations for Perinatal Care at the Limit of Vi-
ability suggest that life support should be continued as
long as there is reasonable hope for survival and the in-
fant’s burden of intensive care is acceptable. If, on the oth-
er hand, the health care team and the parents recognise that,
in the light of a very poor prognosis, the burden of the cur-
rently used therapies has become disproportionate, redirec-
tion of care is appropriate [10].
Indications for LTOP – fetal anomalies
In our cohort, the majority of LTOPs (89%) followed the
detection of fetal anomalies. Swiss law does not allow
LTOP for fetopathic indications per se, but only if the fetal
anomalies are considered to be severe enough to cause
significant maternal psychological distress. This contrasts
with induced abortion laws in many other countries. In his
global review of second trimester induced abortion laws,
Boland found that 69 out of 191 countries specifically au-
thorise induced abortions for fetal impairments [11]. The
definitions of what sort of fetal impairment is sufficient-
ly serious to justify an induced abortion vary consider-
ably. Specific time limits on induced abortion for fetal im-
pairments are mentioned in only some of these laws (16
weeks in 5 countries, 24 weeks in 10 countries, 32 weeks
in 1 country, “viability” in 2 countries) [11]. Interestingly,
Swiss law does not define any time limits.
It has been reported that significant differences concerning
practice of LTOP exist between Swiss hospitals, both with
regard to accepted indications and method of termination.
This may lead to LTOP tourism – both within Switzerland
and abroad [9].
The finding that CNS malformations, chromosomal anom-
alies, severe CHD and multiple malformations were the
most commonly encountered diagnostic categories of fetal
anomalies (accounting for 59% of all LTOP cases in the
present study) has been reported from other European
countries [6, 12] (tables 2 and 3). For example, in a French
population-based cohort study, Monier et al. found that the
same diagnostic categories were responsible for 70% of all
LTOPs performed between 22 and 31 completed weeks of
pregnancy [13]. The EUROCAT working group analysed
routinely collected data on congenital anomalies from 19
registries in 12 European countries in which LTOP for fetal
anomalies is legal. Of all LTOPs performed at a gestational
age of 24 weeks or more, 81% were due to CNS malfor-
mations, chromosomal anomalies, severe CHD or multiple
malformations [6].
In our study, at less than 24 weeks of gestation, CNS mal-
formations was the leading diagnostic category for LTOP,
accounting for 29% of the LTOPs in this gestational age
group. In contrast, at later stages of gestation, CNS mal-
formations accounted for only 13% of all LTOPs, and mis-
cellaneous disorders accounted for the majority (41%) (fig.
3, table S2). In an analysis of 53,000 pregnancies from a
single centre in the USA, Schechtman et al. observed that
severe CNS anomalies appear to provide a much greater
incentive for induced abortion than non-CNS anomalies of
the same severity. In fact, the probability of termination for
grade 3 CNS anomalies (defined as an anomaly with the
potential for serious impact on quality of life) was higher
than for grade 4 non-CNS anomalies (defined as anomalies
incompatible with life) [12].
Congenital malformations are increasingly diagnosed in
utero as a result of advances in prenatal screening [14];
however, prognostic uncertainty can be considerable and
should be acknowledged when parents are counselled.
There are malformations, such agenesis of the corpus cal-
losum (five patients in our cohort), for which the neurode-
velopmental outcome cannot be reliably predicted, particu-
larly if this is an isolated finding (one patient in our cohort)
(table S3 in appendix 2). In fact, it has been reported to
be normal in the majority of cases. Nevertheless, fine and
gross motor control, coordination, language and cognitive
status can be impaired in some of these children. In addi-
tion, neurodevelopmental and overall outcome depend on
associated anomalies that are not always detected prenatal-
ly [15].
The most severe malformations are often termed “lethal”.
However, Wilkinson et al. warned that this term is flawed
as there is no agreed definition, and its use hinders clear
communication [16]. Even for some of the most frequently
cited lethal malformations (renal agenesis, anencephaly,
thanatophoric dwarfism, trisomy 13 or 18, holoprosen-
cephaly, triploidy and hydranencephaly) occasional long-
term survivors have been reported. Wilkinson et al. argued
that the term should be avoided altogether and be replaced
by a set of five key questions [16]: (1) What is the diag-
nosis and how certain is it? (2) What is the likelihood of
survival beyond the newborn period if life-sustaining treat-
ment is provided? (3) What is the likely duration of sur-
vival if life-sustaining treatment is provided? (4) What is
the range of possible physical or cognitive impairments if
the newborn survives? (5) What is the burden of treatment
required to keep the baby alive?. Information given to the
prospective parents should be precise, comprehensive and
unbiased. Healthcare professionals ought to be aware that
the way messages are relayed (so-called message framing)
significantly influences the parents’ decisions [17].
Indications for LTOP – maternal emergencies
The most frequent medical conditions that led to LTOP be-
cause of maternal emergencies were premature prolonged
rupture of membranes, preeclampsia and psychiatric disor-
ders (table 3). In the present study, maternal emergencies
contributed only 11% of all LTOPs, and the majority of
them (n = 18; 11 live births, 7 stillbirths) occurred at less
than 24 weeks of gestation. The fact that none of the live
born infants received any life-sustaining therapies is not
surprising since the current Swiss guidelines for perinatal
care at the limit of viability recommend that comfort care is
appropriate for most infants born at less than 24 complet-
ed weeks of gestation. Provisional intensive care should
be initiated only in selected cases with favourable prenatal
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indicators for improved survival and neurodevelopmental
outcome [10].
Only four infants were born after LTOP for maternal emer-
gencies at more than 24 completed weeks of gestation. For
the three live born infants, a birthweight of less than 500
g in two infants and chorioamnionitis in one infant were
probably considered to be significant negative prognostic
factors leading to a decision not to attempt resuscitation of
these infants in the delivery room.
Overlapping borders
The timing of LTOP is likely to be influenced by the cur-
rent Swiss guidelines on perinatal care, which suggest the
grey zone of the limit of viability to be around 24 weeks
of gestation [10]. The fact that LTOPs are judged to be
more acceptable at earlier gestational ages, when extrauter-
ine survival is not possible, potentially exerts significant
time pressure on the decision-making process.
On the other hand, the present study also demonstrated that
the lower border of the limit of viability can be crossed
when LTOPs are performed in Switzerland. Although 65%
(n = 126) of LTOPs occurred below the current limit of vi-
ability (<24 0/7 weeks), 18% (n = 36) fell into what is con-
sidered to be the grey zone of the limit of viability (24 0/7
to 24 6/7 weeks) and another 17% (n = 33) were performed
at an even later stage (>24 6/7 weeks) (figs 2 and 3).
According to a recently published study from France, a
country with a liberal attitude towards induced abortions,
LTOPs are responsible for almost a quarter of all very
preterm births between 22 0/7 and 31 6/7 weeks of ges-
tation [13]. Compared with Switzerland, higher rates of
LTOPs at more advanced gestational ages were observed in
the French study: only 36% were performed at less than 24
weeks of gestation, 25% at 24 weeks of gestation, and 39%
at 25 0/7 to 27 6/7 weeks of gestation. At least in part, this
can be explained by the fact that second trimester screen-
ing ultrasound examinations are scheduled at 22–24 weeks
of gestation in France, as opposed to 19–22 weeks of ges-
tation in many other European countries [13]. A potential
advantage of second trimester screening at a later stage in
pregnancy is that it might reduce prognostic uncertainty.
High incidence of live births after LTOP
The fact that 39% of infants born after LTOP showed signs
of life after birth is not surprising since the induction of fe-
tal death by injection of a cardioplegic drug is rarely prac-
tised in Switzerland. The rate of live births did not corre-
late with gestational age: it peaked at 24 weeks of gestation
and then decreased again (fig. 2). This can perhaps be ex-
plained by the more severe fetal impairments required by
Swiss law for LTOPs at more advanced gestational ages.
Alternatively, there may be some unreported cases of fetal
deaths caused by injection of a cardioplegic drug.
In their population-based cohort study from France,
Monier et al. found that fetal death caused by injection of
a cardioplegic drug was common, with an overall rate of
73%, increasing from 48% and 59% at 22 and 23 weeks of
gestation, respectively, to 80–92% at later stages of preg-
nancy [13]. This contrasts very strongly with a recorded
overall rate of only 1.5% in the present study from Switzer-
land. In their guidelines concerning LTOP for fetal abnor-
mality, the Royal College of Obstetricians and Gynaecol-
ogists in the UK recommends that fetal death caused by
injection of a cardioplegic drug be routinely offered after
21 6/7 weeks of gestation because live birth becomes in-
creasingly common after 22 weeks of gestation: “Where
the fetal abnormality is not lethal and termination of preg-
nancy is being undertaken after 21 6/7 weeks of gestation,
failure to perform feticide could result in live birth and sur-
vival, an outcome that contradicts the intention of the abor-
tion” [13].
The use of analgo-sedative drugs for palliative care of the
neonate was reported for only 1 of 76 live born patients.
It was therefore either extremely rare or, alternatively, in-
completely documented. This is obviously of concern and
contrasts with the approach taken to infants dying follow-
ing redirection of care after admission to a NICU, where
more than 50% of patients receive opiates and/or benzo-
diazepines [7]. Available evidence from the literature sug-
gests that this is a common phenomenon in the delivery
room setting and not restricted to preterm infants [18–20].
Limitations
Data collection was restricted to infants born between 22
0/7 to 27 6/7 weeks of gestation in Swiss level III perinatal
centres. Therefore, LTOPs outside of this gestational age
range (<22 0/7 weeks or >27 6/7 weeks) were not recorded.
It would have been particularly interesting to have had data
on LTOPs after 27 6/7 weeks of gestation, which were not
collected as a result of the initial study design. Further-
more, some ELGANs (including those born after LTOP)
who died in institutions not certified as perinatal centres
might have been missed. However, comparison with data
provided by the Swiss Federal Statistical Office shows that
the group of infants born after LTOP in other hospitals is
likely to be small (personal communication). Finally, med-
ical records are hospital specific and non-uniform; data
quality is likely to vary. There may be hospital-specific da-
ta sources to which the investigators did not have access.
Therefore, the possibility that some cases were misclassi-
fied or missed altogether cannot be excluded.
Conclusions
To the best of our knowledge, this is the first comprehen-
sive study of LTOPs between 22 0/7 and 27 6/7 weeks of
gestation in Switzerland. LTOPs contribute significantly to
mortality rates among ELGANs. LTOPs have an important
impact on extremely preterm birth and perinatal mortali-
ty rates, and should be included in statistical analyses. De-
tailed documentation of both live and stillbirths after LTOP
should be collected in a dedicated specialised registry [13].
Currently, documentation of LTOPs is often incomplete.
Uniform reporting should be established and include infor-
mation on indication(s), the decision-making process, the
method of termination used and details of palliative care
provided after live births.
Live births are common among infants delivered in the
context of LTOP. Such infants are entitled to benefit from
comprehensive palliative care; they should not be treated
differently from infants born after spontaneous labour or
induction of labour for maternal reasons who die in the de-
livery room or in the NICU after redirection of care.
As suggested by a recent statement of the Swiss National
Ethics Committee [8], development of national guidelines
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for LTOPs would be highly desirable to harmonise practice
and guarantee equal standards of care, regardless of where
the induced abortion takes place. Clearly defined roles
and tasks of gynaecologists, midwives and neonatologists
would ensure good interprofessional collaboration and
ease the emotional burden for parents and professionals
confronted with such difficult situations. In addition, ade-
quate follow-up with psychological support of parents hav-
ing experienced LTOP should be guaranteed. The roles of
fetal death induced by injection of a cardioplegic drug and
palliative births (continuation of pregnancy after detection
of severe fetal anomalies followed by spontaneous birth
and comfort care) should be explored.
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Indications for late termination of pregnancy
Appendix 2 is available as a separate file at https://smw.ch/
article/doi/smw.2020.20186.
Table S1: Details of cases with fetal death caused by injection of a cardioplegic drug.
Case Indication for LTOP Gestational age (weeks) Birthweight (g)
1 Cystic fibrosis 24 6/7 620
2 Mosaicism with partial trisomy 17q and partial monosomy 12p, hy-
poplastic aortic arch
25 4/7 730
3 Trisomy 9 27 2/7 730
Table S2: Indications for late termination of pregnancy with gestational age, birthweight and rate of live births.
Indication for LTOP n % of all LTOP Median gestational age in
weeks
(range)




CNS malformations 46 23.6 23 3/7





Chromosomal anomalies 28 14.3 23 2/7





CHD 23 11.8 23 4/7





Maternal emergencies 21 10.8 23 0/7





Multiple malformations 17 8.7 23 3/7





Skeletal disorders 11 5.6 23 3/7





Oligo-/anhydramnion 11 5.6 23 0/7





Renal malformations 8 4.1 23 3/7





Severe IUGR 7 3.6 24 3/7





Fetal infections 6 3.1 23 5/7





Pulmonary malformation 5 2.6 23 1/7





TTTS 4 2.1 24 4/7





Cystic fibrosis 3 1.5 24 6/7





Fetal hydrops 2 1.0 24 3/7























Total 195 100 23 3/7





CNS = central nervous system; CHD = congenital heart disease; IUGR = intrauterine growth restriction; TTTS = twin-twin transfusion syndrome; LTOP = late termination of preg-
nancy
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